These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease. González-Barca E; Domingo-Domenech E; Capote FJ; Gómez-Codina J; Salar A; Bailen A; Ribera JM; López A; Briones J; Muñoz A; Encuentra M; de Sevilla AF; ; ; Haematologica; 2007 Nov; 92(11):1489-94. PubMed ID: 18024397 [TBL] [Abstract][Full Text] [Related]
24. Successful treatment with rituximab of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation. Jericho H; Weinstein J; Melin-Aldana H; Leuer KC; Wyers M; Alonso EM; Ekong UD J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):e2-4. PubMed ID: 24378523 [No Abstract] [Full Text] [Related]
25. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S; Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985 [TBL] [Abstract][Full Text] [Related]
26. Successful treatment of intraocular post-transplant lymphoproliferative disorder with intravenous rituximab. Iu LP; Yeung JC; Loong F; Chiang AK Pediatr Blood Cancer; 2015 Jan; 62(1):169-72. PubMed ID: 25174958 [TBL] [Abstract][Full Text] [Related]
27. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature. Banks CA; Meier JD; Stallworth CR; White DR Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273 [TBL] [Abstract][Full Text] [Related]
28. Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation. Worth A; Conyers R; Cohen J; Jagani M; Chiesa R; Rao K; Goulden N; Veys P; Amrolia PJ Br J Haematol; 2011 Nov; 155(3):377-85. PubMed ID: 21910716 [TBL] [Abstract][Full Text] [Related]
29. Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder. Czyzewski K; Styczynski J; Krenska A; Debski R; Zajac-Spychala O; Wachowiak J; Wysocki M Leuk Lymphoma; 2013 Mar; 54(3):503-6. PubMed ID: 22873830 [TBL] [Abstract][Full Text] [Related]